Alankit will undertake the verification of pending e-KYC enrollments through the Beneficiary Identification System (BIS) platform provided by the National Health Authority (NHA).
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
GEMTESA is the first and only beta-3 agonist approved for the treatment of men with OAB symptoms who are receiving pharmacological therapy for BPH
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
This curated geriatric care package - Varishtha Aarogya Vardaan -- includes a comprehensive range of essential blood tests specifically curated for seniors.
Exploring new opportunities within the fast-growing market of microfluidics
Divalproex Sodium Delayed-Release Capsules USP, 125 mg have an estimated market size of US$ 61.1 million for twelve months ending September 2024 according to IQVIA
Laurus Labs informs that Eight Roads Ventures and F-Prime Capital (Investors) have together invested Rs. 120 crores in Laurus Bio
Bevqolva 25 mg/mL concentrate for infusion will be available in 4 mL (100 mg) and 16 mL (400 mg) single-use vials for infusion into veins
The company will receive GMP compliance certificate which will further help to accelerate the business growth across the globe
Subscribe To Our Newsletter & Stay Updated
